Home
About
Overview
Sharing Data
ORCID
Help
History (3)
B cell infiltration in systemic sclerosis-associated interstitial lung disease.
Diet-induced protection against lipopolysaccharide includes increased hepatic NO production.
Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study.
Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study. J Child Adolesc Psychopharmacol. 2003; 13(3):311-7.
View in:
PubMed
subject areas
Adolescent
Age of Onset
Antipsychotic Agents
Benzodiazepines
Child
Drug Resistance
Female
Follow-Up Studies
Humans
Male
Pirenzepine
Prospective Studies
Psychiatric Status Rating Scales
Schizophrenia, Childhood
authors with profiles
Robert Allan Mester